Mustang Bio Files 8-K for Operations and Financials
Ticker: MBIO · Form: 8-K · Filed: Mar 11, 2024 · CIK: 1680048
Sentiment: neutral
Topics: financial-reporting, operations
TL;DR
Mustang Bio dropped an 8-K on 3/11 for financials and ops - check it for the deets.
AI Summary
Mustang Bio, Inc. filed an 8-K on March 11, 2024, to report on its results of operations and financial condition, as well as to file financial statements and exhibits. The filing does not contain specific financial figures or operational details within the provided text, but indicates a formal reporting event.
Why It Matters
This filing serves as an official update on Mustang Bio's financial status and operational results, which is crucial information for investors and stakeholders to assess the company's performance.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of operational and financial information, not indicating any immediate adverse events.
Key Players & Entities
- Mustang Bio, Inc. (company) — Registrant
- March 11, 2024 (date) — Date of earliest event reported
- 001-38191 (other) — Commission File Number
- 47-3828760 (other) — IRS Employer Identification No.
- 377 Plantation Street Worcester, Massachusetts 01605 (address) — Principal Executive Offices
- 781-652-4500 (phone_number) — Registrant's telephone number
FAQ
What specific financial results are being reported in this 8-K?
The provided text indicates the filing is for 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits', but does not detail the specific financial figures within this excerpt.
What is the primary purpose of this 8-K filing for Mustang Bio?
The primary purpose is to report on the company's results of operations and financial condition, and to file necessary financial statements and exhibits.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on March 11, 2024.
What is Mustang Bio's principal executive office address?
Mustang Bio's principal executive office is located at 377 Plantation Street, Worcester, Massachusetts 01605.
What is Mustang Bio's commission file number?
Mustang Bio's commission file number is 001-38191.
Filing Stats: 518 words · 2 min read · ~2 pages · Grade level 9.8 · Accepted 2024-03-11 16:30:31
Key Financial Figures
- $0.0001 — ch registered Common Stock, par value $0.0001 per share MBIO NASDAQ Capital Marke
Filing Documents
- tm248266d1_8k.htm (8-K) — 24KB
- tm248266d1_ex99-1.htm (EX-99.1) — 81KB
- image_001.jpg (GRAPHIC) — 5KB
- 0001104659-24-033015.txt ( ) — 294KB
- mbio-20240311.xsd (EX-101.SCH) — 3KB
- mbio-20240311_lab.xml (EX-101.LAB) — 33KB
- mbio-20240311_pre.xml (EX-101.PRE) — 22KB
- tm248266d1_8k_htm.xml (XML) — 3KB
02
Item 2.02. Results of Operations and Financial Condition. On March 11, 2024, Mustang Bio, Inc. issued a press release to provide a corporate update and to announce its financial results for the fiscal year ended December 31, 2023. A copy of such press release is being furnished as Exhibit 99.1 to this Current Report on Form 8-K. The information, including Exhibit 99.1, in this Current Report on Form 8-K is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in this Current Report on Form 8-K shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, except as shall otherwise be expressly set forth by specific reference in such filing.
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. The following exhibit is furnished herewith: Exhibit Number Description 99.1 Press release issued by Mustang Bio, Inc., dated March 11, 2024. 104 Cover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Mustang Bio, Inc. (Registrant) Date: March 11, 2024 By: /s/ Manuel Litchman, M.D. Manuel Litchman, M.D. President and Chief Executive Officer